EQUITY (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Feb. 16, 2022	Jan. 03, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock Split Terms			All common stock numbers and exercise prices in this Note are reflected on a post reverse split (5 to 1) basis, which reverse split was effectuated on February 9, 2018.
Options re-issued to directors			15,900,000
Exercise price			$ 0.05
Risk free interest			1.37%
Dividend yield			0.00%
Volatility			142.00%
Market price	$ 0.05		$ 0.05
Options for active directors						300,000
Options expense for reprice			$ 31,807
Options expected life			5 years
Options vest period			6 months
Total number of options repriced					900,000
Number of shares issued				297,673
Value of shares issued				$ 70,810
Loss on shares issued				8,685
Option expense	$ 699		$ 821,995	$ 109,874
Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options re-issued to directors			900,000
Officer options granted			15,000,000
Exercise price			$ 0.07
Years for options			3 years
Recorded option expense			$ 751,744
Risk free interest			1.35%
Dividend yield			0.00%
Volatility			174.00%
Market price	$ 0.07		$ 0.07
Option expected life			3 years
Director [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Risk free interest			1.90%
Dividend yield			0.00%
Volatility			153.00%
Market price	$ 0.08		$ 0.08
Options expense for reprice			$ 38,444
Options expected life			5 years
Options terms extended			5 years